All blog posts
Total 171 results for
Showing 12 out of 171 results
27 四月 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 三月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
19 一月 2026
Where is the UPC after two and a half years - and what to expect in 2026?
15 十二月 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
03 九月 2025
Herbert Smith Freehills Kramer comments for LSIPR on small molecule litigation in the UPC
31 七月 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
21 七月 2025
Trends emerging as the UPC enters its third year
13 五月 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 四月 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
03 七月 2024
Council of the EU adopts position on the EU compulsory licensing regulation
02 五月 2024
HSF publishes Practical Law practice note on the Unitary Patent
12 四月 2024
HSF Patent team named best in Europe by Managing IP
Showing 12 out of 171 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
雷鹏
科伟史密夫斐尔凯迈联营办公室合伙人, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London